• Wall Street analysts think Lyell Immunopharma (LYEL) could surge 176.02%: Read this before placing a bet MSN Sat, 04 Jul 2026 19:36:06 GMT
• Lyell Immunopharma updates pipeline strategy as cell therapy field evolves AD HOC NEWS Fri, 03 Jul 2026 14:59:14 GMT
• lyell immunopharma, inc. (lyel) latest stock news & headlines Yahoo Finance Thu, 02 Jul 2026 17:28:22 GMT
• Wall Street Analysts Think Lyell Immunopharma (LYEL) Could Surge 176.02%: Read This Before Placing a Bet Yahoo Finance Thu, 02 Jul 2026 13:55:03 GMT
• Form 4 Lyell Immunopharma Inc For: 1 July By Investing.com Investing.com UK Wed, 01 Jul 2026 16:52:01 GMT
• Innovative Cellular Therapeutics moves 76K Lyell (LYEL) shares as broker commission Stock Titan Wed, 01 Jul 2026 16:37:47 GMT
• Lyell Immunopharma stock maintained at Market Outperform by Citizens Investing.com Wed, 01 Jul 2026 07:00:00 GMT
• Lyell at H.C. Wainwright cell therapy event: pipeline data build momentum Investing.com Canada Tue, 30 Jun 2026 19:33:42 GMT
• Lyell at H.C. Wainwright cell therapy conference: data and catalysts Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Lyell Immunopharma, Inc.(NasdaqGS: LYEL) added to Russell 2000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 15:33:30 GMT
• lyell immunopharma, inc.(nasdaqgs:lyel) added to russell microcap value benchmark index marketscreener.com Mon, 29 Jun 2026 13:43:18 GMT
• Lyell Immunopharma, Inc.(NasdaqGS: LYEL) added to Russell 2000 Dynamic Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• lyell immunopharma, inc.(nasdaqgs:lyel) added to russell small cap completeness index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Lyell Immunopharma, Inc. Actuals & Estimates (NASDAQ:LYEL) TradingView Fri, 26 Jun 2026 02:28:04 GMT
• Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) loses 39.7% in 4 weeks, here's why a trend reversal may be around the corner MSN Thu, 25 Jun 2026 03:58:25 GMT
• LYEL Financials: Revenue Breakdown, Margins & Competitor Comparison Intellectia AI Wed, 24 Jun 2026 23:02:16 GMT
• Form 4 Lyell Immunopharma Inc For: 24 June By Investing.com Investing.com Nigeria Wed, 24 Jun 2026 16:37:16 GMT
• lyell immunopharma inc (lyel) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) major holder transfers shares as commission Stock Titan Fri, 19 Jun 2026 02:08:38 GMT
• innovative cellular therapeutics (lyel partner) reports 3m lyell immunopharma shares Stock Titan Thu, 18 Jun 2026 20:07:11 GMT
• Lyell Immunopharma (LYEL) major holder transfers shares as commission Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Innovative Cellular Therapeutics (LYEL) crosses 12.3% ownership after milestone Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• lyell immunopharma | 4: statement of changes in beneficial ownership of securities-10% owner innovative cellular therapeutics hold... Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• lyell immunopharma | 3: initial statement of beneficial ownership of securities- innovative cellular therapeutics holdings ltd - m... Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• lyell immunopharma inc (lyel) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 20:57:44 GMT
• lyell immunopharma inc (lyel) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 20:57:21 GMT
• lyell immunopharma inc (lyel) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 20:56:57 GMT
• Lyell Immunopharma Inc (LYEL) Financial Health: Profitability & Balance Sheet Analysis TradingKey Wed, 17 Jun 2026 20:34:13 GMT
• lyell immunopharma inc (lyel) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 20:29:22 GMT
• lyell immunopharma inc (lyel) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 10:27:16 GMT
• lyell immunopharma inc (lyel) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 09:53:37 GMT
• lyell immunopharma inc (lyel) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• lyell immunopharma inc (lyel) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• lyell immunopharma cso gary k. lee sells $2,459 in lyel stock Investing.com Canada Mon, 15 Jun 2026 23:45:31 GMT
• lyell immunopharma shareholders back governance at 2026 meeting TipRanks Mon, 15 Jun 2026 21:04:24 GMT
• Citizens upgrades Lyell Immunopharma stock price target on trial progress By Investing.com Investing.com Canada Mon, 15 Jun 2026 10:11:36 GMT
• Lyell Immunopharma president and CEO Lynn Seely sells $7,337 in stock Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• Lyell Immunopharma COO Stephen Hill sells $1,683 in shares Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• Lyell Immunopharma (LYEL) CEO’s 388-share tax-related stock sale detailed in Form 4 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Lyell Immunopharma (LYEL) COO’s 89-share sale tied to RSU tax withholding Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Lyell Immunopharma (LYEL) VP auto-sells shares to cover RSU tax withholding Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) cso reports small tax-driven sale of company shares Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• lyell immunopharma (nasdaq: lyel) reports 2026 shareholder meeting and director elections Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Lyell Immunopharma: Undervalued Ahead Of A Major CAR-T Inflection (NASDAQ:LYEL) Seeking Alpha Sat, 13 Jun 2026 07:00:00 GMT
• lyell immunopharma shows strong potential with durable, safe ronde-cel therapy and key trial data expected by 2h26. Pluang Sat, 13 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) director receives 9,250 options at $13.22 strike Stock Titan Fri, 12 Jun 2026 20:17:30 GMT
• lyell immunopharma targets 2027 fda filing as car-t pipeline advances MSN Fri, 12 Jun 2026 12:12:44 GMT
• Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients w... GlobeNewswire Fri, 12 Jun 2026 07:00:00 GMT
• Lyell Immunopharma (LYEL) director awarded 9,250 stock options at $13.22 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Lyell reports safety data for ronde-cel in lymphoma trial Investing.com Fri, 12 Jun 2026 07:00:00 GMT
• director at lyell immunopharma (lyel) receives new option grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• new safety data and translational findings for ronde-cel in relapsed or refractory large b-cell lymphoma announced by lyell immuno... Quiver Quantitative Fri, 12 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) director receives option grant for 9,250 shares at $13.22 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• lyell immunopharma | 4: statement of changes in beneficial ownership of securities-director rieflin william jl Moomoo Fri, 12 Jun 2026 07:00:00 GMT
• lyell immunopharma shows updated safety data for ronde-cel in patients with large b-cell lymphoma TradingView Fri, 12 Jun 2026 07:00:00 GMT
• [form 4] lyell immunopharma, inc. insider trading activity Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) director receives 9,250-share option grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) director granted 9,250 stock options at $13.22 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Lyell Immunopharma (LYEL) CMO logs small tax-driven stock sale on Form 4 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: nuvalent (nuvl), lyell immunopharma (lyel) and biocardia (bcda) The Globe and Mail Wed, 10 Jun 2026 07:00:00 GMT
• lyel reiterated by hc wainwright & co. -- price target maintained at $45 GuruFocus Tue, 09 Jun 2026 12:29:27 GMT
• H.C. Wainwright reiterates Lyell Immunopharma stock rating on safety data By Investing.com Investing.com Canada Tue, 09 Jun 2026 11:41:16 GMT
• Is Lyell Immunopharma (NASDAQ:LYEL) In A Good Position To Deliver On Growth Plans? Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• Here's Why We're Watching Lyell Immunopharma's (NASDAQ:LYEL) Cash Burn Situation simplywall.st Tue, 09 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Lyell Immunopharma(LYEL.US) With Buy Rating, Maintains Target Price $45 Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• citizens upgrades lyell immunopharma stock rating on safety data Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• lyell immunopharma amends lyl273 phase 1 trial to phase 1/2 grafa.com Mon, 08 Jun 2026 14:36:00 GMT
• Lyell Immunopharma Provides Update on Safety Profile of GlobeNewswire Mon, 08 Jun 2026 07:00:00 GMT
• New regimen cuts gut side effects in Lyell's LYL273 colon cancer trial Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• lyell immunopharma issues colorectal cancer drug safety update Benzinga Mon, 08 Jun 2026 07:00:00 GMT
• lyell immunopharma's cancer therapy shows improved safety in phase 1 study Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• lyell to present ronde-cel lymphoma trial data at eha congress Investing.com Australia Fri, 05 Jun 2026 07:00:00 GMT
• lyell immunopharma (lyel) loses 39.7% in 4 weeks, here's why a trend reversal may be around the corner MSN Fri, 05 Jun 2026 06:50:18 GMT
• lyell immunopharma to present phase 1/2 data on ronde-cel car t therapy for large b-cell lymphoma at eha 2026 Pluang Fri, 05 Jun 2026 00:56:50 GMT
• lyell immunopharma to present phase 1/2 ronde-cel safety and translational data in large b-cell lymphoma at eha 2026 - profit reco... newsline.com Thu, 04 Jun 2026 21:13:14 GMT
• Lyell Immunopharma to Present Phase 1/2 Clinical Trial Data on Rondecabtagene Autoleucel at EHA 2026 Congress Quiver Quantitative Thu, 04 Jun 2026 07:00:00 GMT
• Lyell Immunopharma (LYEL) Loses 39.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hemat... GlobeNewswire Thu, 04 Jun 2026 07:00:00 GMT
• lyell car t study reports low-grade side effects in lymphoma Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• lyell to present ronde-cel lymphoma trial data at eha congress Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• Lyell Immunopharma, Inc. Stock 12‑Month Price Target Cut to $37.17, Implies 150% Upside TradingView Wed, 03 Jun 2026 07:00:00 GMT
• bofa securities maintains lyell immunopharma(lyel.us) with sell rating, maintains target price $12 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• h.c. wainwright reiterates lyell immunopharma stock rating at buy Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• lyell immunopharma stock (us55083r1041): nasdaq-listed car-t developer lines up goldman sachs health Ad-hoc-news.de Tue, 02 Jun 2026 07:00:00 GMT
• lyell immunopharma q1 2026 earnings: eps beats estimates by 54.4% as stock declines 13.18% newsline.com Tue, 02 Jun 2026 07:00:00 GMT
• lyell immunopharma announces participation in goldman sachs 47th annual global healthcare conference 2026 GlobeNewswire Mon, 01 Jun 2026 12:00:00 GMT
• lyell immunopharma stock (us55083r1041): shares edge higher after new ronde-cel data and recent q1 2 Ad-hoc-news.de Mon, 01 Jun 2026 07:00:00 GMT
• car t-cell cancer therapy developer lyell to stream goldman sachs chat june 8 Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• lyell quiet as bigger car-t question lingers for investors Bez Kabli Sun, 31 May 2026 07:00:00 GMT
• lyell immunopharma (lyel) holds steady with modest gains amid technical consolidation - ichimoku kumo break newsline.com Thu, 28 May 2026 07:00:00 GMT
• Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances Yahoo Finance Wed, 27 May 2026 07:00:00 GMT
• lyell immunopharma q1 2026 earnings: narrower loss surprises expectations amid clinical progress - subscription growth report newsline.com Wed, 27 May 2026 07:00:00 GMT
• lyell immunopharma (lyel) falls sharply: key support levels in focus after 6.9% drop - fund manager survey The Legal Advocate Tue, 26 May 2026 15:48:07 GMT
• lyell immunopharma (lyel) q1 2026 earnings: narrower loss beats estimates as biotech advances pipeline newsline.com Mon, 25 May 2026 04:47:38 GMT
• lyell immunopharma (lyel) q1 2026 earnings: narrower loss beats estimates as biotech advances pipeline newsline.com Sun, 24 May 2026 07:00:00 GMT
• lyell immunopharma q1 2026 earnings: narrower loss beats estimates as pipeline progress continues - operating margin analysis newsline.com Sun, 24 May 2026 07:00:00 GMT
• down 33.7% in 4 weeks, here's why you should you buy the dip in lyell immunopharma (lyel) MSN Sat, 23 May 2026 13:15:02 GMT
• lyell immunopharma advances next-gen cell thera... | pluang – crypto, stocks, gold & funds Pluang Sat, 23 May 2026 07:00:00 GMT
• lyell gains buy rating on leadership in cd19/20 car-t and ronde-cel progress; analyst reiterates $45 price target TipRanks Thu, 21 May 2026 21:51:30 GMT
• down 33.7% in 4 weeks, here's why you should you buy the dip in lyell immunopharma (lyel) MSN Thu, 21 May 2026 20:54:26 GMT
• lyell immunopharma stock (us55083r1041): analyst boosts price target as cell therapy pipeline advanc AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• lyell immunopharma (lyel) surges +6.76%, nearing $18.08 resistance 2026-05-20 - standard deviation newsline.com Wed, 20 May 2026 07:00:00 GMT
• Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL) Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• lyell immunopharma stock (us55083r1041): focus on cash runway after recent car-t pipeline updates AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• lyell immunopharma (lyel) slips -6.23%, testing $16.95 support 2026-05-15 - call resistance newsline.com Fri, 15 May 2026 07:00:00 GMT
• arch funds and directors disclose shared control of 3.25m lyel shares (lyel) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• lyell immunopharma (lyel) delivers q1 2026 beat — eps $-1.10 vs $-2.41 expected - earnings weakness phase The Legal Advocate Fri, 15 May 2026 07:00:00 GMT
• lyell immunopharma to participate in investor conferences during may geneonline.com Tue, 12 May 2026 12:47:16 GMT
• lyell immunopharma announces participation in may investor conferences GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• cancer cell therapy firm lyell offers investor talks online may 19–20 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• lyell immunopharma (lyel) entities each report 4.3% ownership in amended 13g Stock Titan Mon, 11 May 2026 07:00:00 GMT
• lyell immunopharma (nasdaq:lyel) upgraded to hold at wall street zen MarketBeat Sun, 10 May 2026 05:41:01 GMT
• explore investments/jeff bezos report 6.6% stake in lyell (lyel) Stock Titan Fri, 08 May 2026 07:00:00 GMT
• lyell records $24 mln loss in q1, provides updates on car-t cell therapies for cancer treatment RTTNews Thu, 07 May 2026 15:47:00 GMT
• lyell gains buy rating on leadership in cd19/20 car-t and ronde-cel progress; analyst reiterates $45 price target TipRanks Thu, 07 May 2026 07:00:00 GMT
• h.c. wainwright maintains lyell immunopharma(lyel.us) with buy rating, maintains target price $45 Moomoo Thu, 07 May 2026 07:00:00 GMT
• Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026 GlobeNewswire Wed, 06 May 2026 07:00:00 GMT
• lyell starts phase 3 lymphoma dosing, says cash runway reaches q3 2027 Stock Titan Wed, 06 May 2026 07:00:00 GMT
• lyell immunopharma (nasdaq: lyel) trims q1 loss and advances car t trials Stock Titan Wed, 06 May 2026 07:00:00 GMT
• lyell immunopharma (nasdaq: lyel) cuts quarterly loss and raises equity capital Stock Titan Wed, 06 May 2026 07:00:00 GMT
• brief-lyell immunopharma q1 net income usd -24.153 million TradingView Wed, 06 May 2026 07:00:00 GMT
• lyell reports new clinical data from trial of large b-cell lymphoma therapy MSN Tue, 05 May 2026 10:29:00 GMT
• lyell immunopharma (lyel) to release quarterly earnings on tuesday MarketBeat Tue, 05 May 2026 07:00:00 GMT
• baird initiates lyell immunopharma(lyel.us) with buy rating, announces target price $49 富途牛牛 Tue, 05 May 2026 06:07:01 GMT
• lyell immunopharma (lyel) price target increased by 27.27% to 14.28 MSN Mon, 04 May 2026 12:55:38 GMT
• lyel sec filings - lyell immunopharma, inc. 10-k, 10-q, 8-k forms Stock Titan Sun, 03 May 2026 09:10:49 GMT
• lyell immunopharma (lyel) price target increased by 27.27% to 14.28 MSN Sun, 03 May 2026 07:57:28 GMT
• lyell reports new clinical data from trial of large b-cell lymphoma therapy MSN Sun, 03 May 2026 06:14:47 GMT
• bofa securities maintains lyell immunopharma(lyel.us) with sell rating, maintains target price $12 Moomoo Sat, 02 May 2026 17:59:29 GMT
• lyell immunopharma (nasdaq:lyel) upgraded by robert w. baird to strong-buy rating MarketBeat Sat, 02 May 2026 11:34:44 GMT
• lyell immunopharma (nasdaq:lyel) downgraded to sell rating by wall street zen MarketBeat Sat, 02 May 2026 06:41:56 GMT
• lyell immunopharma (lyel) price target increased by 27.27% to 14.28 MSN Sat, 02 May 2026 05:42:09 GMT
• bofa securities maintains lyell immunopharma(lyel.us) with sell rating, maintains target price $12 富途牛牛 Fri, 01 May 2026 11:31:00 GMT
• bofa reiterates lyell immunopharma stock underperform on rival exit Investing.com Fri, 01 May 2026 07:00:00 GMT
Lyell Immunopharma Inc(NASDAQ:LYEL) 
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer. South San Francisco, California, United States.
Share this website to your friends